Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 12

Results: 36

Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2517, doi. 10.1038/sj.leu.2403103
By:
- Eckert, C.;
- Scrideli, C.A.;
- Taube, T.;
- Songia, S.;
- Wellmann, S.;
- Manenti, M.;
- Seeger, K.;
- Biondi, A.;
- Cazzaniga, G.
Publication type:
Article
Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2513, doi. 10.1038/sj.leu.2403123
By:
- Fischer, M.;
- Bijman, M.;
- Molin, D.;
- Cormont, F.;
- Uyttenhove, C.;
- van Snick, J.;
- Sundström, C.;
- Enblad, G.;
- Nilsson, G.
Publication type:
Article
Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS.
Published in:
2003
By:
- Chim, C.S.;
- Fung, T.K.;
- Liang, R.
Publication type:
Letter
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2318, doi. 10.1038/sj.leu.2403135
By:
- Gabert, J.;
- Beillard, E.;
- van der Velden, V.H.J.;
- Bi, W.;
- Grimwade, D.;
- Pallisgaard, N.;
- Barbany, G.;
- Cazzaniga, G.;
- Cayuela, J.M.;
- Cavé, H.;
- Pane, F.;
- Aerts, J.L.E;
- De Micheli, D.;
- Thirion, X.;
- Pradel, V.;
- González, M.;
- Viehmann, S.;
- Malec, M.;
- Saglio, G.
Publication type:
Article
Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2418, doi. 10.1038/sj.leu.2403152
By:
- Dvorak, P.;
- Dvorakova, D.;
- Doubek, M.;
- Faitova, J.;
- Pacholikova, J.;
- Hampl, A.;
- Mayer, J.
Publication type:
Article
A further milestone towards comprehensive standardization of quantitative RT-PCR protocols for leukemic fusion gene transcripts has been reached.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2383, doi. 10.1038/sj.leu.2403137
By:
- Hochhaus, A.
Publication type:
Article
Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2435, doi. 10.1038/sj.leu.2403139
By:
- Billard, C.;
- Kern, C.;
- Tang, R.;
- Ajchenbaum-Cymbalista, F.;
- Kolb, J.-P.
Publication type:
Article
Somatic mitochondrial DNA mutations in adult-onset leukaemia.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2487, doi. 10.1038/sj.leu.2403146
By:
- He, L.;
- Luo, L.;
- Proctor, S.J.;
- Middelton, P.G.;
- Blakely, E.L.;
- Taylor, R.W.;
- Turnbull, D.M.
Publication type:
Article
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2426, doi. 10.1038/sj.leu.2403147
By:
- Dürig, J.;
- Nückel, H.;
- Cremer, M.;
- Führer, A.;
- Halfmeyer, K.;
- Fandrey, J.;
- Möröy, T.;
- Klein-Hitpass, L.;
- Dührsen, U.
Publication type:
Article
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2474, doi. 10.1038/sj.leu.2403136
By:
- Beillard, E.;
- Pallisgaard, N.;
- van der Velden, V.H.J.;
- Bi, W.;
- Dee, R.;
- van der Schoot, E.;
- Delabesse, E.;
- Macintyre, E.;
- Gottardi, E.;
- Saglio, G.;
- Watzinger, F.;
- Lion, T.;
- van Dongen, J.J.M.;
- Hokland, P.;
- Gabert, J.
Publication type:
Article
High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis.
Published in:
2003
By:
- Liebisch, P.;
- Wendl, C.;
- Wellmann, A.;
- Kröber, A.;
- Schilling, G.;
- Goldschmidt, H.;
- Einsele, H.;
- Straka, C.;
- Bentz, M.;
- Stilgenbauer, S.;
- Döhner, H.
Publication type:
Letter
Unsolved issues in CLL biology and management.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2385, doi. 10.1038/sj.leu.2403154
By:
- Dighiero, G.
Publication type:
Article
EBV-related lymphoproliferative disorders in immunocompetent patients.
Published in:
2003
By:
- Oosterveld, M.;
- Lesterhuis, W.J.;
- MacKenzie, M.;
- van Krieken, J.H.J.M.
Publication type:
Letter
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2358, doi. 10.1038/sj.leu.2403156
By:
- Larson, R.A.;
- Daley, G.W.;
- Shiffer, C.A.;
- Porcu, P.;
- Pui, C.-H.;
- Marie, J.-P.;
- Steelman, L.S;
- Bertrand, F.E.;
- McCubrey, J.A.
Publication type:
Article
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon a/ara-C.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2392, doi. 10.1038/sj.leu.2403157
By:
- Müller, M.C.;
- Gattermann, N.;
- Lahaye, T.;
- Deininger, M.W.N.;
- Berndt, A.;
- Fruehauf, S.;
- Neubauer, A.;
- Fischer, T.;
- Hossfeld, D.K.;
- Schneller, F.;
- Krause, S.W.;
- Nerl, C.;
- Sayer, H.G.;
- Ottmann, O.G.;
- Waller, C.;
- Aulitzky, W.;
- le Coutre, P.;
- Freund, M.;
- Merx, K.
Publication type:
Article
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2401, doi. 10.1038/sj.leu.2403158
By:
- Banford, S.;
- Rudzki, Z.;
- Harper, A.;
- Grigg, A.;
- Taylor, K.;
- Durrant, S.;
- Arthur, C.;
- Browett, P.;
- Schwarer, A.P.;
- Ma, D.;
- Seymour, J.F.;
- Bradstock, K.;
- Joske, D.;
- Lynch, K.;
- Gathmann, I.;
- Hughes, T.P.
Publication type:
Article
Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2492, doi. 10.1038/sj.leu.2403160
By:
- Matsuno, N.;
- Osato, M.;
- Yamashita, N.;
- Yanagida, M.;
- Nanri, T.;
- Fukushima, T.;
- Motoji, T.;
- Kusumoto, S.;
- Towatari, M.;
- Suzuki, R.;
- Naoe, T.;
- Nishii, K.;
- Shigesada, K.;
- Ohno, R.;
- Mitsuya, H.;
- Ito, Y.;
- Asou, N.
Publication type:
Article
Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.
Published in:
2003
By:
- Hummel, M.;
- Buchheidt, D.;
- Reiter, S.;
- Bergmann, J.;
- Hofheinz, R.;
- Hehlmann, R.
Publication type:
Case Study
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
Published in:
2003
By:
- Khorshid, O.;
- de Meis, E.;
- Martin, T.;
- Jones, R.B.;
- Shpall, E.J.;
- Nieto, Y.;
- Khouri, I.;
- Shahjahan, M.;
- Gajewski, J.;
- Giralt, S.;
- Champlin, R.;
- de Lima, M.
Publication type:
Letter
GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia.
Published in:
2003
By:
- Jazbec, J.;
- Aplenc, R.;
- Dolzan, V.;
- Debeljak, M.;
- Jereb, M.
Publication type:
Letter
Reply to Hasle et al.
Published in:
2003
By:
- Gassas, A.;
- Freedman, M.H.;
- Mandel, K.;
- Dror, Y.
Publication type:
Letter
Reply to Gassas et al.
Published in:
2003
By:
- Hasle, H.;
- Niemeyer, C.M.;
- Chessells, J.M.;
- Baumann, I.;
- Bennett, J.M.;
- Kerndrup, G.;
- Head, D.R.
Publication type:
Letter
Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.
Published in:
2003
By:
- le Coutre, P.;
- Kreuzer, K.A.;
- Massenkeil, G.;
- Baskaynak, G.;
- Zschieschang, P.;
- Genvresse, I.;
- Lupberger, J.;
- Mapara, M.;
- Dörken, B.;
- Arnold, R.
Publication type:
Letter
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2444, doi. 10.1038/sj.leu.2403172
By:
- Buesche, G.;
- Hehlmann, R.;
- Hecker, H.;
- Heimpel, H.;
- Heinze, B.;
- Schmeil, A.;
- Pfirrmann, M.;
- Gomez, G.;
- Tobler, A.;
- Herrmann, H.;
- Kappler, M.;
- Hasford, J.;
- Buhr, T.;
- Kreipe, H.-H.;
- Georgii, A.
Publication type:
Article
Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cells.
Published in:
2003
By:
- Spaenij-Dekking, E.H.A.;
- Van Delft, J.;
- E. Van der Meijden, J.;
- Hiemstra, H.S.;
- Falkenburg, J.H.F.;
- Koning, F.;
- Drijfhout, J.W.;
- Kluin-Nelemans, J.C.;
- Van Der Meijden, E
Publication type:
journal article
Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2500, doi. 10.1038/sj.leu.2403175
By:
- Costello, R.T.;
- Mallet, F.;
- Barbarat, B.;
- Schiano de Colella, J.-M.;
- Sainty, D.;
- Sweet, R.W.;
- Truneh, A.;
- Olive, D.
Publication type:
Article
Telomerase is limiting the growth of acute myeloid leukemia cells.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2410, doi. 10.1038/sj.leu.2403177
By:
- Röth, A.;
- Vercauteren, S.;
- Sutherland, H.J.;
- Lansdorp, P.M.
Publication type:
Article
B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.
Published in:
2003
By:
- Bertrand, F.E.;
- Spengeman, J.D.;
- Shah, N.;
- LeBien, T.W.
Publication type:
journal article
Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2508, doi. 10.1038/sj.leu.2403179
By:
- M. Suguro-Katayama, W.;
- Suzuki, R.;
- Kasugai, Y.;
- Nakamura, T.;
- Suzuki, H.;
- Hosokawa, Y.;
- Shiku, H.;
- Nakamura, S.;
- Seto, M.
Publication type:
Article
Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2460, doi. 10.1038/sj.leu.2403180
By:
- Benesch, M.;
- Platzbecker, U.;
- Ward, J.;
- Deeg, H.J.;
- Leisenring, W.
Publication type:
Article
Influence of stochastics on quantitative PCR in the detection of minimal residual disease.
Published in:
2003
By:
- Rawer, D.;
- Borkhardt, A.;
- Wilda, M.;
- Kropf, S.;
- Kreuder, J.
Publication type:
Letter
Response to Influence of stochastics on quantitative PCR in the detection of minimal residual disease by Rawer et al.
Published in:
2003
By:
- Arlinghaus, R.;
- Lin, H.;
- Kim, H.-W.;
- Guo, J.Q.
Publication type:
Letter
Reply to Arlinghaus et al.
Published in:
2003
By:
- Rawer, D.;
- Borkhardt, A.;
- Wilda, M.;
- Kropf, S.;
- Kreuder, J.
Publication type:
Letter
Reply to Rawer et al (second letter).
Published in:
2003
By:
- Arlinghaus, R.;
- Lin, H.;
- Guo, J.Q.;
- Kim, H.-W.;
- Ke, S.
Publication type:
Letter
Reply to Arlinghaus et al (second letter).
Published in:
2003
By:
- Rawer, D.;
- Borkhardt, A.;
- Wilda, M.;
- Kropf, S.;
- Kreuder, J.
Publication type:
Letter
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
Published in:
Leukemia (08876924), 2003, v. 17, n. 12, p. 2257, doi. 10.1038/sj.leu.2403202
By:
- van Dongen, J. J. M.;
- Langerak, A. W.;
- Brüggemann, M.;
- Evans, P. A. S.;
- Hummel, M.;
- Lavender, F. L.;
- Delabesse, E.;
- Davi, F.;
- Schuuring, E.;
- García-Sanz, R.;
- van Krieken, J. H. J. M;
- Droese, J.;
- González, D.;
- Bastard, C.;
- White, H. E.;
- Spaargaren, M.;
- González, M.;
- Parreira, A.;
- Smith, J. L.;
- Morgan, G. J.
Publication type:
Article

Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 12

Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes.

Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.

Disruption of INK4/CDK/Rb cell cycle pathway by gene hypermethylation in multiple myeloma and MGUS.

Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program.

Increased expression of fibroblast growth factor receptor 3 in CD34+ BCR-ABL+ cells from patients with chronic myeloid leukemia.

A further milestone towards comprehensive standardization of quantitative RT-PCR protocols for leukemic fusion gene transcripts has been reached.

Flavopiridol downregulates the expression of both the inducible NO synthase and p27<sup>kip1</sup> in malignant cells from B-cell chronic lymphocytic leukemia.

Somatic mitochondrial DNA mutations in adult-onset leukaemia.

ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis.

Unsolved issues in CLL biology and management.

EBV-related lymphoproliferative disorders in immunocompetent patients.

Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002.

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon a/ara-C.

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype.

Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.

Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia.

Reply to Hasle et al.

Reply to Gassas et al.

Autologous peripheral blood stem cell transplantation of stem cells harvested in imatinib-induced complete cytogenetic remission: an example of in vivo purging in CML.

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.

Synaptojanin 2 is recognized by HLA class II-restricted hairy cell leukemia-specific T cells.

Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity.

Telomerase is limiting the growth of acute myeloid leukemia cells.

B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression.

Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma.

Expression of FLIP<sub>Long</sub> and FLIP<sub>Short</sub> in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.

Influence of stochastics on quantitative PCR in the detection of minimal residual disease.

Response to Influence of stochastics on quantitative PCR in the detection of minimal residual disease by Rawer et al.

Reply to Arlinghaus et al.

Reply to Rawer et al (second letter).

Reply to Arlinghaus et al (second letter).

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936.